Home NDC 0074-0282 DECNUPAZ
Product NDC 0074-0282
11-digit product format 000740282
Labeler code 0074
Product ID 0074-0282_a7f31acd-4120-420a-ab5d-10415866e41a
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name pivekimab sunirine-pvzy
Dosage form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route INTRAVENOUS
Labeler AbbVie Inc.
Application BLA761460
Marketing category BLA
Marketing start 2026-05-27
Substance PIVEKIMAB SUNIRINE
Active strength 2 mg/mL
Listing certified through 2027-12-31
Current FDA listing Yes Additional Listing Data#
Finished product Yes
Brand name base DECNUPAZ
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength PIVEKIMAB SUNIRINE 2 mg/mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination L15LO3W1XX Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2744303 Internal RxNorm lookup 2744309 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 761460 Decnupaz pivekimab sunirine-pvzy 351(a) Rx 2026-08-01
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Sample Status 0074-0282-02 00074028202 1 VIAL, SINGLE-DOSE in 1 CARTON (0074-0282-02) / 1.15 mL in 1 VIAL, SINGLE-DOSE 2026-05-27 0 Current